The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
The long-term goal of our PIC is to develop effective strategies that can be applied clinically at the point-of-care to prevent, intercept, or detect PDAC at an early stage, thereby reducing PDAC burden and saving lives.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• 18 years of age or older
• Moffitt Cancer Center patients presenting with a pancreatic cyst, and/or inherited syndrome that predisposes them to pancreatic ductal adenocarcinoma (PDAC)
• Moffitt Cancer Center patients undergoing evaluation for localized/early stage PDAC.
• Moffitt Cancer Center patients with a combination of PDAC risk factors such as a history of chronic or new-onset diabetes, pancreatitis, obesity, tobacco exposure, toxin exposure and/or heavy alcohol consumption.
Locations
United States
Florida
Moffitt Cancer Center
RECRUITING
Tampa
Time Frame
Start Date: 2022-10-06
Estimated Completion Date: 2026-02
Participants
Target number of participants: 500
Treatments
All participants
Participants include patients scheduled to see the clinical team in the Pancreas Interception Center (PIC) which will be housed in the Moffitt GI Clinic.
Related Therapeutic Areas
Sponsors
Leads: H. Lee Moffitt Cancer Center and Research Institute